Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00801554 · ClinicalTrials.gov registry record

Autism Spectrum Disorders (ASD) Characterization Study

A clinical trial of Autism Spectrum Disorders, sponsored by Massachusetts General Hospital.

Completed
Registry status
26
Enrollment target
1
Study location

NCT00801554: Completed study of Autism Spectrum Disorders, sponsored by Massachusetts General Hospital.

NCT00801554 is a study of Autism Spectrum Disorders that has completed, run by Massachusetts General Hospital. The registered enrollment target is 26 participants, below the 167-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00801554, a study of Autism Spectrum Disorders, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
26 participants
Enrollment target
1
Study location

Study Summary

The overarching aim of the study is to characterize children and adults with ASDs, and compare them with age-matched controls in relation to their functioning in family, academic, employment, and social spheres. Subjects will be comprehensively assessed in multiple non-overlapping domains of functioning, using psychiatric, cognitive, and psychosocial instruments.

Conditions Studied

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Cambridge

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2008-10
Est. Completion 2010-04
Massachusetts General Hospital

2,032 total trials

What the finished NCT00801554 record still lists

NCT00801554 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 167-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (84% lower).

The record links to 1 condition, with Autism Spectrum Disorders appearing as the primary indexed condition, and to 0 interventions.

NCT00801554 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00801554 about?

NCT00801554 is a clinical study titled "Autism Spectrum Disorders (ASD) Characterization Study". The overarching aim of the study is to characterize children and adults with ASDs, and compare them with age-matched controls in relation to their functioning in family, academic, employment, and social spheres. Subjects will be comprehensively assessed in multiple non-overlapping domains of functio...

What is the current status of trial NCT00801554?

This trial is currently completed. The enrollment target is 26 participants. The study started on 2008-10. Estimated completion is 2010-04.

What conditions does trial NCT00801554 study?

This clinical trial studies the following conditions: Autism Spectrum Disorders.

Who is sponsoring clinical trial NCT00801554?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00801554 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00801554's enrollment target sits among peer trials

26 14th of 20 higher than 7 of 20 other Autism Spectrum Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Autism Spectrum Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02646475 · 26 participants · Phase 1

    Metabolic Effects of Angiotensin-(1-7)

  • NCT03603223 · 26 participants · Phase 2

    Pembrolizumab in Treating Participants With Leukoplakia

  • NCT04063592 · 26 participants · NA

    AMI Construction in Lower Extremity Residual Limbs

  • NCT04906460 · 26 participants · Phase 1

    Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00801554, the US trial registry maintained by the National Library of Medicine. NCT00801554 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.